November 8, 2018Open Access

Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study

Key Points

Key points are not available for this paper at this time.

Abstract

Therefore, combination therapy of Rg5 and chemotherapy drugs is a strategy for the adjuvant chemotherapy, which encourages further pharmacokinetic and clinical studies.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Feng et al. (Thu,) studied this question.

synapsesocial.com/papers/69da86d50f0ab7a47c83594b https://doi.org/https://doi.org/10.1016/j.jgr.2018.10.007

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Role of ginsenosides, the main active components of Panax ginseng , in inflammatory responses and diseases2016 · 551 citations
2Novel strategies to prevent the development of multidrug resistance (MDR) in cancer2017 · 210 citations
3Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies2017 · 52 citations
4Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance2014 · 315 citations
5Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer2017 · 231 citations

Demander à l'IA

Bookmark

View Full Paper